Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$18.67 - $24.56 $5.13 Million - $6.75 Million
-275,000 Reduced 61.11%
175,000 $4.26 Million
Q4 2022

Feb 14, 2023

SELL
$17.24 - $23.95 $236,187 - $328,115
-13,700 Reduced 2.95%
450,000 $9.63 Million
Q3 2022

Nov 14, 2022

SELL
$9.4 - $18.59 $341,220 - $674,817
-36,300 Reduced 7.26%
463,700 $8.32 Million
Q2 2022

Aug 15, 2022

BUY
$9.12 - $18.9 $455,999 - $944,999
50,000 Added 11.11%
500,000 $4.81 Million
Q1 2022

May 16, 2022

SELL
$12.15 - $16.83 $2.13 Million - $2.95 Million
-175,000 Reduced 28.0%
450,000 $7.57 Million
Q4 2021

Feb 16, 2022

SELL
$13.83 - $18.78 $1.38 Million - $1.88 Million
-100,000 Reduced 13.79%
625,000 $10.5 Million
Q2 2021

Aug 11, 2021

SELL
$5.69 - $7.17 $2.28 Million - $2.87 Million
-400,000 Reduced 35.56%
725,000 $4.58 Million
Q1 2021

May 14, 2021

SELL
$5.08 - $6.89 $1.27 Million - $1.72 Million
-250,000 Reduced 18.18%
1,125,000 $6.95 Million
Q4 2020

Feb 16, 2021

BUY
$5.65 - $7.66 $2.12 Million - $2.87 Million
375,000 Added 37.5%
1,375,000 $9.5 Million
Q3 2020

Nov 16, 2020

BUY
$4.01 - $6.29 $401,000 - $629,000
100,000 Added 11.11%
1,000,000 $5.64 Million
Q2 2020

Aug 14, 2020

BUY
$3.06 - $6.6 $218,915 - $472,170
71,541 Added 8.64%
900,000 $4.59 Million
Q1 2020

May 15, 2020

BUY
$2.83 - $8.44 $222,038 - $662,193
78,459 Added 10.46%
828,459 $2.85 Million
Q4 2019

Feb 14, 2020

BUY
$0.93 - $8.58 $697,500 - $6.44 Million
750,000 New
750,000 $6.44 Million

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.